EUVIMEDEUVIMED entdecken
Crossref

Imidazolate‐Stabilized Cu(III): Dioxygen to Oxides at Type 3 Copper Sites

Tao A. G. Large, William Keown, J. Brannon Gary, Linus Chiang, T. Daniel P. Stack

Angewandte Chemie · 27.01.2025 · 137 (5)

DOI: 10.1002/ange.202416967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie, online erschienen am 27.11.2024. Verfasst von Tao A. G. Large und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: National Institutes of Health, National Institute of General Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imidazole ligation of metals through histidine is extensive among metalloproteins, yet the role of the imidazol ate conjugate base is often neglected, despite its potential accessibility when bonded to an oxidized metal center. Using synthetic models of oxygenated tyrosinase enzymes ligated exclusively by monodentate imidazoles, we find that deprotonation of the μ 2 ‐η 2 :η 2 ‐peroxidodicopper(II) species triggers redox isomerization to an imidazol ate ‐ligated bis(μ 2 ‐oxido)dicopper(III) species. Formal two‐electron oxidation to Cu(III) remains biologically unprecedented, yet is effected readily by addition of base. Spectrophotometric titrations by UV/Visible/near‐IR and copper K‐edge X‐ray absorption spectroscopies are interpreted most simply as two cooperative, 2H + transformations in which the peroxide O−O is cleaved in the first step. Elaboration from simple imidazoles to a protected histidine extends this isomerization into an amino acid environment. The role of phenolate as a base suggests this four‐electron reduction of O 2 is energetically viable in a biological context and requires only two copper centers, which act as two‐electron shuttles when imidazole deprotonation assists. This existential precedent of viable imidazol ate intermediates invites speculation into an alternative mechanism for phenol hydroxylation not previously considered at Type 3 copper sites such as tyrosinases. Structural biological evidence suggests imidazolate ligation of copper may be more widespread than generally understood.

Förderung

  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Large, T. A. G., Keown, W., Gary, J. B., Chiang, L., & Stack, T. D. P. (2025). Imidazolate‐Stabilized Cu(III): Dioxygen to Oxides at Type 3 Copper Sites. Angewandte Chemie, 137(5). https://doi.org/10.1002/ange.202416967

Vancouver

Large TAG, Keown W, Gary JB, Chiang L, Stack TDP. Imidazolate‐Stabilized Cu(III): Dioxygen to Oxides at Type 3 Copper Sites. Angewandte Chemie. 2025;137(5). doi:10.1002/ange.202416967

BibTeX
@article{Large2025,
  author = {Large, Tao A. G. and Keown, William and Gary, J. Brannon and Chiang, Linus and Stack, T. Daniel P.},
  title = {Imidazolate‐Stabilized Cu(III): Dioxygen to Oxides at Type 3 Copper Sites},
  journal = {Angewandte Chemie},
  year = {2025},
  volume = {137},
  number = {5},
  doi = {10.1002/ange.202416967}
}
Kostenlos starten →